PortfoliosLab logoPortfoliosLab logo
ISIN
US0727303028
CUSIP
072730302

Highlights

Market Cap
$39.06B
Enterprise Value
$80.47B
EPS (TTM)
-$0.53
Total Revenue (TTM)
$45.36B
Gross Profit (TTM)
$26.91B
EBITDA (TTM)
$7.30B
Year Range
$7.19 - $14.85
ROA (TTM)
-1.92%
ROE (TTM)
-7.18%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

BAYRY Performance Chart

Bayer AG PK (BAYRY) is down 7.9% since the beginning of the year. At $10 per share, BAYRY is trading 33.1% below its 52-week high of $15. Investors who bought $1,000 worth of BAYRY shares 5 years ago would now be looking at an investment worth $675.


Loading charts...

S&P 500 Index

Returns By Period

Bayer AG PK (BAYRY) has returned -7.86% so far this year and 40.02% over the past 12 months. Over the last ten years, BAYRY has returned -6.51% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.


Bayer AG PK

1D
0.61%
1M
-8.22%
YTD
-7.86%
6M
0.09%
1Y
40.02%
3Y*
-10.63%
5Y*
-7.55%
10Y*
-6.51%

Benchmark (S&P 500 Index)

1D
-0.74%
1M
4.90%
YTD
10.35%
6M
10.28%
1Y
26.52%
3Y*
20.83%
5Y*
12.30%
10Y*
13.66%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BAYRY Monthly Returns History

Based on dividend-adjusted daily data since Sep 27, 2007, BAYRY's average daily return is +0.02%, while the average monthly return is +0.32%. At this rate, an investment would double in approximately 18.1 years.

Historically, 47% of months were positive and 53% were negative. The best month was Apr 2011 with a return of +39.7%, while the worst month was Oct 2008 at -32.2%. The longest winning streak lasted 12 consecutive months, and the longest losing streak was 5 months.

On a daily basis, BAYRY closed higher 46% of trading days. The best single day was Apr 6, 2011 with a return of +24.6%, while the worst single day was Oct 27, 2008 at -42.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202621.53%-6.46%-6.67%-2.41%-5.55%-5.78%-7.86%
202515.57%5.14%1.52%9.99%7.28%6.65%2.65%6.20%0.85%-6.51%13.61%22.88%122.78%
2024-15.17%-3.07%0.92%-4.32%5.75%-8.81%5.97%3.49%9.72%-20.07%-24.22%-4.87%-46.92%
202321.15%-4.56%7.13%2.57%-11.01%-1.14%5.64%-6.10%-12.47%-10.42%-20.74%8.33%-25.35%
202213.65%-3.98%18.31%-4.29%12.53%-16.55%-2.35%-9.09%-12.42%13.67%10.81%-11.68%0.35%
20212.47%0.61%3.79%5.72%-0.99%-4.93%-2.53%-6.77%-1.81%4.26%-11.00%5.07%-7.34%

Benchmark Metrics

Bayer AG PK has an annualized alpha of -3.34%, beta of 0.76, and R2 of 0.21 versus S&P 500 Index. Calculated based on daily prices since September 28, 2007.

  • This stock participated in 118.35% of S&P 500 Index downside but only 76.38% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.21 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-3.34%
Beta
0.76
0.21
Upside Capture
76.38%
Downside Capture
118.35%

Return for Risk

Risk / Return Rank

BAYRY ranks 68 for risk / return — better than 68% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


BAYRY Risk / Return Rank: 6868
Overall Rank
BAYRY Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
BAYRY Sortino Ratio Rank: 6969
Sortino Ratio Rank
BAYRY Omega Ratio Rank: 6666
Omega Ratio Rank
BAYRY Calmar Ratio Rank: 6666
Calmar Ratio Rank
BAYRY Martin Ratio Rank: 6767
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Bayer AG PK (BAYRY) and compare them to S&P 500 Index.


BAYRYBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

1.02

2.24

-1.22

Sortino ratio

Return per unit of downside risk

1.67

3.07

-1.41

Omega ratio

Gain probability vs. loss probability

1.20

1.41

-0.20

Calmar ratio

Return relative to maximum drawdown

1.29

2.93

-1.64

Martin ratio

Return relative to average drawdown

3.16

13.52

-10.36

Dividends

Dividend History

Bayer AG PK provided a 0.32% dividend yield over the last twelve months, with an annual payout of $0.03 per share.


0.00%1.00%2.00%3.00%4.00%5.00%6.00%7.00%$0.00$0.20$0.40$0.60$0.80$1.00$1.20$1.4020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$0.03$0.03$0.03$0.63$0.55$0.59$0.54$0.55$1.00$1.31$0.69$0.63

Dividend yield

0.32%0.29%0.60%6.85%4.27%4.48%3.61%2.71%5.69%4.20%2.65%2.03%

Monthly Dividends

The table displays the monthly dividend distributions for Bayer AG PK. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.00$0.03$0.00$0.00$0.03
2025$0.00$0.00$0.00$0.03$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.03
2024$0.00$0.00$0.00$0.03$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.03
2023$0.00$0.00$0.00$0.00$0.63$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.63
2022$0.00$0.00$0.00$0.00$0.55$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.55
2021$0.00$0.00$0.00$0.59$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.59

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Bayer AG PK. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Bayer AG PK was 83.33%, occurring on Dec 26, 2024. The portfolio has not yet recovered.

The current Bayer AG PK drawdown is 65.58%.


Related event

Drawdown

Fall

Recovery

Underwater

2024 bear market2024
-83.33%Dec 2024
9y 9mo
11y 2moMar 2015 - now
Financial crisis2007–2009
-55.34%Mar 2009
1y 2mo3y 6mo
4y 8moJan 2008 - Sep 2012
2015 correction2015
-13.38%Jan 2015
1mo 4d2mo 10d
3mo 14dDec 2014 - Mar 2015
2014 correction2014
-11.88%Oct 2014
4mo 14d1mo 7d
5mo 21dJun 2014 - Nov 2014
2014 correction2014
-11.11%Apr 2014
3mo 15d16d
4mo 1dDec 2013 - May 2014

Drawdown Indicators


BAYRYBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-83.33%

-56.78%

-26.55%

Max Drawdown (1Y)

Largest decline over 1 year

-31.19%

-9.10%

-22.09%

Max Drawdown (3Y)

Largest decline over 3 years

-66.65%

-18.90%

-47.75%

Max Drawdown (5Y)

Largest decline over 5 years

-71.71%

-25.43%

-46.28%

Max Drawdown (10Y)

Largest decline over 10 years

-83.02%

-33.92%

-49.10%

Current Drawdown

Current decline from peak

-65.58%

-0.74%

-64.84%

Average Drawdown

Average peak-to-trough decline

-34.32%

-10.72%

-23.60%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.71%

1.97%

+10.74%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Bayer AG PK over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Bayer AG PK is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for BAYRY relative to other companies in the Drug Manufacturers - General industry. Currently, BAYRY has a P/S ratio of 0.9. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for BAYRY in comparison with other companies in the Drug Manufacturers - General industry. Currently, BAYRY has a P/B value of 1.4. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with BAYRY

Add Bayer AG PK to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with BAYRY